Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Afya ( (AFYA) ).
Afya Limited, the Brazilian medical education and medical practice solutions group, reported that its board approved a substantial cash dividend tied to its 2025 performance. The company, which runs a physician-focused ecosystem from training to practice support, continues to leverage both dividends and share repurchases as key elements of its capital allocation strategy.
On March 12, 2026, Afya’s board authorized its second cash dividend, totaling R$307.4 million, equivalent to 40% of consolidated net income for 2025 and R$3.446838 per share, to be paid in U.S. dollars on April 6, 2026 to shareholders of record as of March 25, 2025. Management emphasized that, alongside an ongoing share buyback program active through December 2026, the company expects to return about half of its 2025 net income to investors, underscoring confidence in its balance sheet strength, long-term growth prospects, and commitment to shareholder returns.
The most recent analyst rating on (AFYA) stock is a Hold with a $17.00 price target. To see the full list of analyst forecasts on Afya stock, see the AFYA Stock Forecast page.
Spark’s Take on AFYA Stock
According to Spark, TipRanks’ AI Analyst, AFYA is a Outperform.
Afya’s strong financial performance and positive earnings call are the most significant factors contributing to its score. The company’s robust revenue growth, profitability, and strategic achievements in the earnings call highlight its potential for future success. Technical analysis indicates some bearish momentum, but valuation metrics suggest the stock is reasonably priced.
To see Spark’s full report on AFYA stock, click here.
More about Afya
Afya Limited is a leading Brazilian medical education group and medical practice solutions provider, listed on Nasdaq and B3. The company operates an end-to-end, physician-centric ecosystem, supporting doctors from entry into medical school through residency preparation, graduation, continuing education, and digital tools that enhance clinical practice across their careers.
Average Trading Volume: 112,730
Technical Sentiment Signal: Sell
Current Market Cap: $1.26B
Learn more about AFYA stock on TipRanks’ Stock Analysis page.